Additionally, studies have shown that the levels of MMP9 in the brain and cerebrospinal fluid (CSF) of AD patients are significantly elevated, and this elevation exhibits a positive correlation with disease severity. The gene discussed is MMP9; the disease is Alzheimer disease.